Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Bipolar Depression
NCT04417049Phase 1Completed
- Sponsor
- University Health Network
- Start
- Jul 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pentoxifylline in bipolar disorder (BD), sponsored by University Health Network. Primary endpoints: Recruitment Rate at 8 weeks and Retention Rate at 8 weeks. Started Jul 2021; status: completed.
02
Drugs
pentoxifylline
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT04417049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417049.